Colorectal Cancer in Native American States or aređenje.
Part of Cancer, Digestive system clinical trials.
This study tests whether a new way of doing a colonoscopy can find more early signs of bowel cancer. It may help people who are due for a routine screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 75 years old
- You are a Native American or Alaska Native person
- You are scheduled for a screening colonoscopy
- You can read and speak English
- You have access to a phone or email
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new program to help American Indian adults get screened for colorectal cancer. If you qualify, you may get support and reminders to complete a simple stool test at home.
This study follows people with colorectal cancer of any stage to learn more about their care and outcomes. It may help researchers improve treatments for future patients.
This study looks at the genes of pancreatic and kidney cancers in Native American patients to learn more about these diseases and potentially find better treatments. If you join, researchers will use your stored tumor sample for genetic testing.
This study aims to understand how to better encourage colorectal cancer screening among American Indian communities. If you join, you will share your views in an interview to help make screening more welcome and accessible for your community.
This study helps African American adults choose an at-home colorectal cancer screening test and make a plan to use it. It aims to make screening easier and more convenient for you.
This study tests a program to help people learn about colorectal cancer screening. If you are 45 to 75 and due for screening, you may be able to join.
Hear when a new CRC Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.